Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$664K Sell
166,037
-20,968
-11% -$79.9K ﹤0.01% 697
2026
Q1
$748K Buy
187,005
+102,699
+122% +$359K ﹤0.01% 659
2025
Q4
$317K Buy
84,306
+9,243
+12% +$37.9K ﹤0.01% 722
2025
Q3
$329K Buy
75,063
+31,336
+72% +$159K ﹤0.01% 715
2025
Q2
$289K Buy
43,727
+66
+0.2% +$388 ﹤0.01% 690
2025
Q1
$221K Buy
43,661
+326
+0.8% +$1.85K ﹤0.01% 692
2024
Q4
$255K Sell
43,335
-104,332
-71% -$684K ﹤0.01% 695
2024
Q3
$1.1M Sell
147,667
-12,786
-8% -$88.9K ﹤0.01% 594
2024
Q2
$1.16M Buy
160,453
+85,257
+113% +$618K ﹤0.01% 559
2024
Q1
$614K Sell
75,196
-2,504
-3% -$20K ﹤0.01% 661
2023
Q4
$535K Sell
77,700
-55,116
-41% -$336K ﹤0.01% 605
2023
Q3
$665K Sell
132,816
-41,534
-24% -$222K ﹤0.01% 603
2023
Q2
$837K Buy
174,350
+9,083
+5% +$36K ﹤0.01% 559
2023
Q1
$635K Buy
165,267
+65,600
+66% +$267K ﹤0.01% 575
2022
Q4
$374K Buy
99,667
+8,599
+9% +$32.8K ﹤0.01% 626
2022
Q3
$337K Buy
91,068
+47,841
+111% +$179K ﹤0.01% 643
2022
Q2
$133K Buy
+43,227
New +$209K ﹤0.01% 686

Other funds holding VTEX

Boston Partners's VTEX Position: Q2 2026 in Review

Boston Partners reduced its VTEX (VTEX) stake by 11% in Q2 2026, selling an estimated $79.9K and leaving 166,037 shares worth $664K. The position accounts for ﹤0.01% of the portfolio, ranked #697.

Boston Partners first reported a position in VTEX in Q2 2022 and has held it in 17 quarters since. The position peaked at $1.16M in Q2 2024. 109 funds tracked by Wall St. Rank hold VTEX as of Q2 2026.

  • Boston Partners held 166,037 shares of VTEX worth $664K as of Q2 2026.
  • Boston Partners sold 20,968 VTEX shares in Q2 2026, an estimated $79.9K.
  • VTEX made up ﹤0.01% of Boston Partners's portfolio in Q2 2026, its #697 holding.
  • Boston Partners first reported a position in VTEX in Q2 2022 and has held it in 17 quarters since.
  • Boston Partners's VTEX position peaked at $1.16M in Q2 2024.
  • 109 funds tracked by Wall St. Rank held VTEX as of Q2 2026.

Based on Boston Partners's 13F filing for Q2 2026, filed 4 Aug 2026.